Dr. Aiken is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
99 Beauvoir Avenue
Fifth Floor
Summit, NJ 07901Phone+1 908-522-5914Fax+1 908-522-5845
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 1981 - 1983
New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1978 - 1981
Baylor College of MedicineResidency, Internal Medicine, 1976 - 1978
Wayne State University School of MedicineClass of 1976
Certifications & Licensure
NJ State Medical License 2017 - 2025
NY State Medical License 1979 - 2025
IL State Medical License 2017 - 2021
PA State Medical License 1982 - 2012
MI State Medical License 1978 - 2006- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors 2014-2023
- America's Top Doctors for Cancer Castle Connolly, 2014-2023
- Marquis Who's Who in America 2011-2023
- Join now to see all
Clinical Trials
- Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas Start of enrollment: 2012 Dec 01
Publications & Presentations
PubMed
- 48 citationsSafety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration.Mark N. Stein, Jyoti Malhotra, Rohinton Tarapore, Usha Malhotra, Ann W. Silk
Journal for Immunotherapy of Cancer. 2019-05-22 - 108 citationsFirst-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid TumorsMark N. Stein, Joseph R. Bertino, Howard L. Kaufman, Tina M. Mayer, Rebecca A. Moss
Clinical Cancer Research. 2017-08-01 - 195 citationsFirst results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.Linda M Liau, Keyoumars Ashkan, David D Tran, Jian L Campian, John E Trusheim
Journal of Translational Medicine. 2018-05-29
Press Mentions
Overlook Medical Center Chosen as SURVIVE Trial Site, Enrolling Patients for New Brain Tumor VaccineFebruary 22nd, 2022
Rutgers Cancer Institute of New Jersey Doctors Named Among ‘Tops’ in Oncology CareJuly 23rd, 2019- A Brain Tumor Vaccine? NJ Hospital One of Three in US Chosen for Landmark Clinical TrialFebruary 24th, 2022
- Join now to see all
Research History
- Director, Neuro-oncology ProgramDirector, Neuro-oncology Program Rutgers-Cancer Institute of New Jersey2015 - 2019
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
